Cognito Therapeutics

Cognito Therapeutics, Aetion team-up to use AI to identify progressing cognitive impairments

Collaboration aims to develop a predictive model to help identify individuals at an increased risk of developing mild cognitive impairment and Alzheimer's

Aetion raises $11.2 Series A for its healthcare analytics platform

With this additional funding, the company will extend the capabilities of its platform, as well as expand and commercialize its solutions.